Literature DB >> 13599489

The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis.

D N KERR, A E READ, R M HASLAM, S SHERLOCK.   

Abstract

Entities:  

Keywords:  ALDOSTERONE/antagonists; ASCITES/etiology and pathogenesis; LIVER CIRRHOSIS/complications

Mesh：

Substances：

Year:  1958        PMID： 13599489     DOI： 10.1016/s0140-6736(58)92464-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Results of treatment from porta-caval anastomosis, lieno-renal anastomosis and hepatic artery ligation.

Authors:  A HUNT
Journal:  Proc R Soc Med       Date:  1959-04

2.  ASCITES in the liver disease.

Authors: 
Journal:  Br Med J       Date:  1960-10-01

3.  The clinical application of aldosterone antagonists in the treatment of oedema.

Authors:  S SHALDON
Journal:  Proc R Soc Med       Date:  1961-04

4.  Use of spironolactone and hydrochlorothiazide in treatment of oedema.

Authors:  R O FARRELLY; R N HOWIE; J D NORTH
Journal:  Br Med J       Date:  1960-07-30

5.  [Disorders of water-electrolyte metabolism in diuretic therapy].

Authors:  H JAHRMAERKER
Journal:  Klin Wochenschr       Date:  1960-04-15

6.  Quantitative comparison of aldosterone antagonists in normal human subjects: prediction of therapeutic potency.

Authors:  G T McInnes; I R Harrison; J R Shelton; R M Perkins
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

7.  Spironolactone.

Authors: 
Journal:  Br Med J       Date:  1967-06-17

8.  [Studies with SU 4885 (metopirone) in patients with refractory ascites and edemas].

Authors:  F H FRANKEN; K IRMSCHER; H von SCHWEINITZ
Journal:  Klin Wochenschr       Date:  1962-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.